Analysts Set Tempus AI, Inc. (NASDAQ:TEM) PT at $68.54

Posted by on Jul 9th, 2026

Shares of Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) have been assigned a consensus recommendation of “Hold” from the fifteen brokerages that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have assigned a buy rating to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $68.5385.

TEM has been the subject of several recent analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Tempus AI in a research note on Wednesday, June 17th. Needham & Company LLC reissued a “buy” rating and issued a $75.00 price target on shares of Tempus AI in a report on Monday, June 1st. BTIG Research restated a “buy” rating and set a $80.00 price objective on shares of Tempus AI in a research note on Monday, June 1st. Freedom Capital upgraded Tempus AI to a “hold” rating in a report on Tuesday, June 30th. Finally, TD Cowen upped their target price on Tempus AI from $65.00 to $68.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th.

Read Our Latest Stock Analysis on TEM

Insiders Place Their Bets

In other Tempus AI news, CFO James William Rogers sold 11,529 shares of the firm’s stock in a transaction on Thursday, June 25th. The shares were sold at an average price of $55.00, for a total transaction of $634,095.00. Following the completion of the transaction, the chief financial officer directly owned 114,866 shares of the company’s stock, valued at $6,317,630. This trade represents a 9.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Eric P. Lefkofsky sold 166,250 shares of the business’s stock in a transaction dated Monday, June 29th. The stock was sold at an average price of $57.48, for a total transaction of $9,556,050.00. Following the completion of the sale, the chief executive officer directly owned 8,775,283 shares of the company’s stock, valued at $504,403,266.84. The trade was a 1.86% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 582,759 shares of company stock valued at $29,838,424. 24.26% of the stock is owned by insiders.

Hedge Funds Weigh In On Tempus AI

Hedge funds have recently bought and sold shares of the company. JPL Wealth Management LLC acquired a new stake in Tempus AI during the third quarter valued at approximately $26,000. Los Angeles Capital Management LLC acquired a new position in shares of Tempus AI in the 4th quarter worth approximately $27,000. Harvest Fund Management Co. Ltd acquired a new position in shares of Tempus AI in the 3rd quarter worth approximately $38,000. Whittier Trust Co. increased its holdings in shares of Tempus AI by 190.0% in the 1st quarter. Whittier Trust Co. now owns 870 shares of the company’s stock valued at $41,000 after acquiring an additional 570 shares during the last quarter. Finally, Lodestone Wealth Management LLC acquired a new stake in shares of Tempus AI during the 4th quarter valued at approximately $42,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Stock Performance

Shares of NASDAQ:TEM opened at $57.27 on Friday. The company has a market cap of $10.28 billion, a P/E ratio of -33.30 and a beta of 3.46. The company has a debt-to-equity ratio of 2.96, a quick ratio of 3.15 and a current ratio of 3.31. Tempus AI has a one year low of $41.73 and a one year high of $104.32. The business’s 50-day simple moving average is $50.92 and its 200 day simple moving average is $54.35.

Tempus AI (NASDAQ:TEM – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.08. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. The business had revenue of $348.12 million during the quarter, compared to the consensus estimate of $345.44 million. During the same period in the prior year, the firm earned ($0.24) earnings per share. The business’s quarterly revenue was up 36.1% compared to the same quarter last year. On average, sell-side analysts forecast that Tempus AI will post -1.35 earnings per share for the current fiscal year.

About Tempus AI

(Get Free Report)

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.

Featured Articles

Analyst Recommendations for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.